{
  "docId": "019de074-2e24-777e-87b3-831358a7e33a",
  "docSlug": "971513439f6499291689438a6a6dd75f",
  "documentTitle": "Compass Therapeutics | Investor Presentation Deck | 20 slides",
  "authorId": "compass-therapeutics",
  "authorName": "Compass Therapeutics",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-01-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 8,
  "pageCount": 20,
  "prevPage": 7,
  "nextPage": 9,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 12,
  "notes": "Clinical trial data presentation.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-2e24-777e-87b3-831358a7e33a/8",
  "deckHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a",
  "deckJsonHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a.json",
  "deckAnchorHref": "/decks/019de074-2e24-777e-87b3-831358a7e33a#slide-8",
  "components": [
    {
      "bbox": {
        "h": 0.085,
        "w": 0.305,
        "x": 0.068,
        "y": 0.245
      },
      "kind": "list",
      "text": "24 patients enrolled and dosed\n1 patient remains on study",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22265d55-6e46-4c27-ac94-b78c777cd77d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.42,
        "w": 0.63,
        "x": 0.042,
        "y": 0.37
      },
      "kind": "table",
      "text": "Endpoint;Value (95% CI);Overall Response Rate (ORR);37.5%;Stable Disease (SD);54.2%;Progression Free Survival (PFS);9.4 m (5.4 – 11.1);Overall Survival (OS);12.5 m (10.9 – NA);Duration of Response;6.9 m (3.5 – NA)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9c6af136-89d6-4424-b5a1-9dd626724a1d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.24,
        "w": 0.28,
        "x": 0.678,
        "y": 0.328
      },
      "kind": "table",
      "text": "Number of previous systemic therapies;ORR;Pts treated in the 2L [n=11];7/11 (63.6%);Pts treated in the 3L [n=13];2/13 (15.4%)",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d374166e-ca1d-4c3a-b474-9ca4f933036c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.045,
        "w": 0.864,
        "x": 0.068,
        "y": 0.155
      },
      "kind": "title",
      "text": "CTX-009 Phase 2 Results (Median follow-up of 12.1 months)",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d4d7ea45-f857-430e-bda2-ba8e0168b794",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 8,
      "from": 3,
      "beatId": "d33bd1e8-59e3-4285-9fff-5d07e1436828",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "Slides 3-8 detail the product, CTX-009, and its clinical trial data.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [
    {
      "to": 8,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "044654bc-2486-4078-b913-f66936c4244b",
      "evidence": "Slides 6-8 present clinical trial data, implying that not investing could mean missing out on a potentially effective treatment.",
      "position": 0,
      "objective": "What are the consequences of not investing in CTX-009?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}